Example: Heart Attack

Clinical Trials on Uveitis

Total 362 results





    • NCT04162314
      Recruiting
      Beta-1,3/1,6-D-Glucan Ganoderma Lucidum on Non-infectious and Idiopathic Uveitis
      Conditions: Uveitis
    • NCT03877575
      Recruiting
      Lyon Uveitis Study
      Conditions: Uveitis
    • NCT01983488
      Unknown status
      Clinical Outcome in Uveitis
      Conditions: Uveitis
    • NCT02911116
      Recruiting
      Ustekinumab (STELARA) for the Treatment of Active Sight-Threatening Uveitis (STAR Study)
      Conditions: Uveitis
    • NCT04183387
      Completed
      Simvastatin in Uveitis
      Conditions: Uveitis
    • NCT02769702
      Terminated
      Open Label Study of Acthar SQ Gel Injection in Patients With Active Anterior Uveitis
      Conditions: Uveitis
    • NCT01124838
      Completed
      Efficacy and Safety of Adalimumab in Subjects With Inactive Uveitis
      Conditions: Uveitis
    • NCT02311192
      Withdrawn
      Grading Scale of Vitreous Haze in Patients With Uveitis Using Ultrasonography
      Conditions: Uveitis
    • NCT02931175
      Recruiting
      ACTH as A Re-emerging theRapy for Uveitis (The ACTHAR Study)
      Conditions: Uveitis
    • NCT01195948
      Completed
      Optiquel® as Corticosteroid-sparing Therapy for Chronic Noninfectious Uveitis
      Conditions: Uveitis
    • NCT02026128
      Recruiting
      Optical Coherence Tomography (OCT) in Uveitis
      Conditions: Uveitis
    • NCT03828019
      Recruiting
      Adalimumab vs. Conventional Immunosuppression for Uveitis Trial
      Conditions: Uveitis
    • NCT04148365
      Recruiting
      Medication Compliance in the Paediatric Uveitis Population Reported by the Patients and Parents
      Conditions: Uveitis
    • NCT01495767
      Completed
      Quality of Life in Juvenile Patients With Uveitis
      Conditions: Uveitis
    • NCT03889860
      Active, not recruiting
      Objective Choroidal Thickness Measurements in Uveitis
      Conditions: Uveitis
    • NCT04354909
      Not yet recruiting
      Soluble CD95 Ligand Role in the Pathophysiology of Non-infectious Active Uveitis
      Conditions: Non-Infectious Active Uveitis
    • NCT04340505
      Recruiting
      Imaging of Uveitis Patients Receiving Injectable Fluocinolone Acetonide Implant
      Conditions: Uveitis
    • NCT03389191
      Recruiting
      A Clinical Trial of Acyclovir for Viral Uveitis
      Conditions: Uveitis
    • NCT02494492
      Suspended
      Treatment of the Bilateral Severe Uveitis by IVT of Regulator T-cells: Study of Tolerance of Dose
      Conditions: Uveitis
    • NCT02656381
      Recruiting
      Uveitis/Intraocular Inflammatory Disease Biobank (iBank)
      Conditions: Uveitis
    • NCT03646890
      Completed
      Epidemiology and Clinical Features of Uveitis in a Tertiary Referral
      Conditions: Uveitis
    • NCT00889421
      Terminated
      Apremilast in the Treatment of Uveitis
      Conditions: Uveitis
    • NCT01261169
      Unknown status
      Mycophenolate Sodium (Myfortic®) in the Treatment of Corticosteroid-refractory Autoimmune Uveitis:Pilot Study
      Conditions: Uveitis
    • NCT01162070
      Completed
      Evaluation of a Standardized Strategy for Uveitis Etiological Diagnosis
      Conditions: Uveitis
    • NCT03554824
      Completed
      Psychosocial Outcomes and Transition Readiness in Uveitis
      Conditions: Uveitis
      Medical Conditions
      Sponsors and Collaborators
      Drug Interventions
      Conditions
      Rare Diseases
      Drug Interventions
      Dietary Supplements
      Sponsor/Collaborators
      Locations